Ball MP

References (3)

Title : The effects of galantamine on psychopathology in chronic stable schizophrenia - Conley_2009_Clin.Neuropharmacol_32_69
Author(s) : Conley RR , Boggs DL , Kelly DL , McMahon RP , Dickinson D , Feldman S , Ball MP , Buchanan RW
Ref : Clinical Neuropharmacology , 32 :69 , 2009
Abstract :
PubMedSearch : Conley_2009_Clin.Neuropharmacol_32_69
PubMedID: 18978489

Title : Galantamine for the treatment of cognitive impairments in people with schizophrenia - Buchanan_2008_Am.J.Psychiatry_165_82
Author(s) : Buchanan RW , Conley RR , Dickinson D , Ball MP , Feldman S , Gold JM , McMahon RP
Ref : Am J Psychiatry , 165 :82 , 2008
Abstract :
PubMedSearch : Buchanan_2008_Am.J.Psychiatry_165_82
PubMedID: 17986678

Title : Initial phase 2 trial of a nicotinic agonist in schizophrenia - Freedman_2008_Am.J.Psychiatry_165_1040
Author(s) : Freedman R , Olincy A , Buchanan RW , Harris JG , Gold JM , Johnson L , Allensworth D , Guzman-Bonilla A , Clement B , Ball MP , Kutnick J , Pender V , Martin LF , Stevens KE , Wagner BD , Zerbe GO , Soti F , Kem WR
Ref : Am J Psychiatry , 165 :1040 , 2008
Abstract :
PubMedSearch : Freedman_2008_Am.J.Psychiatry_165_1040
PubMedID: 18381905